Sysmex Corporation (SSMXY) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Kobe, Japan. The current CEO is Hisashi Ietsugu.
SSMXY has IPO date of 2011-10-17, 10,042 full-time employees, listed on the Other OTC, a market capitalization of $5.5B.
Sysmex Corporation is a Japanese diagnostic instrument manufacturer headquartered in Kobe that develops, manufactures, and sells hematology analyzers, immunochemistry systems, flow cytometers, and related reagents and software globally. The company's product portfolio includes white blood cell differentiation instruments, urine analysis systems, infectious disease and tumor marker assays, cancer diagnostic systems, and digital medicine platforms, serving hospitals, research institutions, and medical centers across approximately 190 countries. Beyond diagnostic instruments, Sysmex provides laboratory information system software, facility management services, nucleic acid analogs, IT solutions, and medical robotics, with a strategic alliance with QIAGEN for cancer companion diagnostics development. Founded in 1968, the company has established itself as a comprehensive in vitro diagnostics provider serving both public and private healthcare institutions worldwide.
